Diagnostic value of CT, PET and combined PET/CT performed with low-dose unenhanced CT and full-dose enhanced CT in the initial staging of lymphoma

被引:0
|
作者
Pinilla, I. [4 ]
Gomez-Leon, N. [4 ]
Del Campo-Del Val, L. [1 ]
Hernandez-Maraver, D. [2 ]
Rodriguez-Vigil, B. [4 ]
Jover-Diaz, R. [3 ]
Coya, J. [4 ]
机构
[1] Hosp Univ Princesa, Dept Radiol, Madrid, Spain
[2] Hosp Univ La Paz, Dept Hematol, Madrid 28046, Spain
[3] Unidad PET TC MDA Anderson, Madrid, Spain
[4] Hosp Univ La Paz, Dept Radiol & Nucl Med, Madrid 28046, Spain
关键词
Positron-emission tomography; Tomography; X-ray computed; Lymphoma; Neoplasm staging; POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKIN-LYMPHOMA; FDG-PET; DISEASE; INVOLVEMENT; NEED;
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim. The aim of this paper was to compare the accuracy of contrast-enhanced computed tomography (CT), positron emission tomography (PET), unenhanced low-dose PET/CT (LD-PET/CT) and full-dose enhanced PET/CT (FD-PET/CT) for the initial staging of lymphoma. Methods. One hundred and one lymphoma patients were examined by [18F]FDG-PET/CT including unenhanced low-dose CT and enhanced full-dose CT. Each modality of PET/CT was evaluated by a nuclear medicine physician and a radiologist unaware of the other modality, while the CT and PET images were interpreted separately by another independent radiologist and nuclear medicine physician respectively. The nodal and extranodal lesions detected by each technique were compared with a reference standard. Results. For nodal assessment, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LR+), and negative LR (LR-) of LD-PET/CT were 97%, 96%, 98%, 95%, 26 and 0.02 respectively, and those of FD-PET/CT were 97%, 97%, 98%, 95%, 36 and 0.02. These results were significantly better than those of PET (sensitivity 82%, specificity 81%, PPV 88%, NPV 72%, LR+ 4.3, LR-0.21). Likewise, both PET/CT displayed a higher sensitivity, NPV and LR-than CT (91%, 84%, 0.1 respectively). For organ evaluation, both modalities of PET/CT also had significantly better sensitivity and NPV than that of PET (LD-PET/CT: sensitivity 92%, NPV 90%; FD-PET/CT sensitivity 94%, NPV 92%; PET: sensitivity 70%, NPV 69%). The sensitivity, specificity, PPV and NPV for bone marrow involvement were 29%, 84%, 45% and 72% respectively for PET, and 29%, 90%, 56%, and 74% for both, LD-PET/CT, and FD-PET/CT. No significant differences were found between LD-PET/CT and FDPET/CT, but FD-PET/CT detected important incidental findings in 5.9% of patients. Conclusion. PET/CT is an accurate technique for the initial staging of lymphomas without significant differences between LD-PET/CT and FD-PET/CT. FDPET/CT detects relevant incidental findings that are missed on LD-PET/CT.
引用
收藏
页码:567 / 575
页数:9
相关论文
共 50 条
  • [1] PET/CT in lymphoma:: Prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT
    Rodriguez-Vigil, Beatriz
    Gomez-Leon, Nieves
    Pinilla, Inmaculada
    Hernandez-Maraver, Dolores
    Coya, Juan
    Martin-Curto, Luis
    Madero, Rosario
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (10) : 1643 - 1648
  • [2] Low-Dose PET/CT and Full-Dose Contrast-Enhanced CT at the Initial Staging of Localized Diffuse Large B-Cell Lymphomas
    Sabate-Llobera, Aida
    Cortes-Romera, Montserrat
    Mercadal, Santiago
    Hernandez-Ganan, Javier
    Pomares, Helena
    Gonzalez-Barca, Eva
    Gamez-Cenzano, Cristina
    CLINICAL MEDICINE INSIGHTS-BLOOD DISORDERS, 2016, 9 : 29 - 32
  • [3] Evaluation of unenhanced low-dose PET/CT as the only imaging technique for staging lymphoma patients
    Rubi Sureda, S.
    Setoain, X.
    Rodriguez, S.
    Ayuso, C.
    Ayuso, J. R.
    Domenech, B.
    Fuster, D.
    Pons, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S241 - S241
  • [4] Evaluation of unenhanced low-dose PET/CT as the only imaging technique for staging lymphoma patients
    Rubi Sureda, S.
    Setoain, X.
    Rodriguez, S.
    Ayuso, C.
    Ayuso, J. R.
    Domenech, B.
    Fuster, D.
    Pons, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (SUPPL 2) : 241 - 241
  • [5] Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT scans for diagnosing ovarian cancer recurrence
    Kitajima, Kazuhiro
    Ueno, Yoshiko
    Suzuki, Kayo
    Kita, Masato
    Ebina, Yasuhiko
    Yamada, Hideto
    Senda, Michio
    Maeda, Tetsuo
    Sugimura, Kazuro
    EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (11) : 3557 - 3562
  • [6] Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrence
    Kazuhiro Kitajima
    Kayo Suzuki
    Yuji Nakamoto
    Yumiko Onishi
    Setsu Sakamoto
    Michio Senda
    Masato Kita
    Kazuro Sugimura
    European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 : 1490 - 1498
  • [7] Low-dose non-enhanced CT versus full-dose contrast-enhanced CT in integrated PET/CT studies for the diagnosis of uterine cancer recurrence
    Kitajima, Kazuhiro
    Suzuki, Kayo
    Nakamoto, Yuji
    Onishi, Yumiko
    Sakamoto, Setsu
    Senda, Michio
    Kita, Masato
    Sugimura, Kazuro
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (08) : 1490 - 1498
  • [8] Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients
    Heusner, Till A.
    Kuemmel, Sherko
    Hahn, Steffen
    Koeninger, Angela
    Otterbach, Friedrich
    Hamami, Monia E.
    Kimmig, Klaus R.
    Forsting, Michael
    Bockisch, Andreas
    Antoch, Gerald
    Stahl, Alexander
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (10) : 1543 - 1550
  • [9] Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients
    Till A. Heusner
    Sherko Kuemmel
    Steffen Hahn
    Angela Koeninger
    Friedrich Otterbach
    Monia E. Hamami
    Klaus R. Kimmig
    Michael Forsting
    Andreas Bockisch
    Gerald Antoch
    Alexander Stahl
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 1543 - 1550
  • [10] EVALUATION OF 18F-FLURODEOXYGLUCOSE PET/CT COMPARED TO CONTRAST-ENHANCED FULL-DOSE PET/CT IN THE MANAGEMENT OF PATIENTS WITH LYMPHOMA
    Fuster, D.
    Navales, I.
    Rubi, S.
    Setoain, X.
    Rodriguez, S.
    Ayuso, C.
    Lopez Guillermo, A.
    Gutierrez, G.
    Pons, F.
    ANNALS OF ONCOLOGY, 2010, 21 : 353 - 353